Chemagen Biopolymer-Technologie AG - Ownership and Business Overview

Life ScienceCompany

Chemagen Biopolymer-Technologie AG Ownership

Who owns Chemagen Biopolymer-Technologie AG?

Chemagen Biopolymer-Technologie AG is owned by Revvity. It was acquired on February 14, 2011.

Chemagen Biopolymer-Technologie AG Business Overview

Where is Chemagen Biopolymer-Technologie AG headquartered?

Chemagen Biopolymer-Technologie AG is headquartered in Baesweiler, Germany.

What sector is Chemagen Biopolymer-Technologie AG in?

Chemagen Biopolymer-Technologie AG is a life science company.

When was Chemagen Biopolymer-Technologie AG founded?

Chemagen Biopolymer-Technologie AG was founded in 1997.

Life Science M&A Summary in 2011

Out of 60 sectors in the Mergr database, life science ranked 11 in number of deals in 2011. The largest life science acquisition in 2011 was Genzyme - which was acquired by Sanofi SA for $20.1B.

Join Mergr to view all 171 acquisitions of life science companies in 2011, including 23 acquisitions by private equity firms, and 148 by strategics.

Chemagen Biopolymer-Technologie AG

Arnold-Sommerfeld-Ring 2,
Baesweiler, 52499
Germany,
+49 2401 805 500
www.chemagen.com

chemagen Biopolymer-Technologie AG, a key player in the field of automated nucleic acid isolation, as part of the Company’s strategy to advance its offerings to the molecular diagnostics and research markets.


 Subscribe to unlock this and 206,153
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 198K M&A Transactions
  • 202K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 80K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Chemagen Biopolymer-Technologie AG

Life Science Companies , Germany Companies